2-206542104-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The ENST00000264377.8(ADAM23):āc.626A>Gā(p.Lys209Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000264377.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM23 | NM_003812.4 | c.626A>G | p.Lys209Arg | missense_variant | 5/26 | ENST00000264377.8 | NP_003803.1 | |
ADAM23 | NM_001410985.1 | c.626A>G | p.Lys209Arg | missense_variant | 5/26 | NP_001397914.1 | ||
ADAM23 | XM_005246932.4 | c.626A>G | p.Lys209Arg | missense_variant | 5/25 | XP_005246989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM23 | ENST00000264377.8 | c.626A>G | p.Lys209Arg | missense_variant | 5/26 | 1 | NM_003812.4 | ENSP00000264377 | P4 | |
ADAM23 | ENST00000374415.7 | c.626A>G | p.Lys209Arg | missense_variant | 5/26 | 5 | ENSP00000363536 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251458Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135904
GnomAD4 exome AF: 0.000363 AC: 530AN: 1461858Hom.: 0 Cov.: 30 AF XY: 0.000345 AC XY: 251AN XY: 727234
GnomAD4 genome AF: 0.000243 AC: 37AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74380
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at